Lab partnership could boost Lifespan’s research stature

LAB TALK: Jennie Liu, left, research scientist, and Jason LaPorte, senior research associate for TriSalus Life Sciences, discuss the TriNav infusion system that will be tested to deliver treatments for pancreatic and liver tumors as part of a partnership with Lifespan Corp. / PBN PHOTO/MICHAEL SALERNO
LAB TALK: Jennie Liu, left, research scientist, and Jason LaPorte, senior research associate for TriSalus Life Sciences, discuss the TriNav infusion system that will be tested to deliver treatments for pancreatic and liver tumors as part of a partnership with Lifespan Corp. / PBN PHOTO/MICHAEL SALERNO

Rhode Island’s largest hospital system is hoping that teaming up with a biotech company could help achieve a breakthrough in developing treatment options for liver and pancreatic tumors. Lifespan Corp. says its new partnership with the Colorado-based TriSalus Life Sciences is more than just about providing space for a tenant to do lab research. It’s

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display